Are you over 18 and want to see adult content?
More Annotations
Ital centar -brave, cilindri, šarke, rigle
Are you over 18 and want to see adult content?
Durable Men's Clothing Raw Denim, Chinos, Tees, USA made
Are you over 18 and want to see adult content?
Adoración y Liberación – La conciliación con el espíritu del mundo no sólo debilita la fe, sino que lle
Are you over 18 and want to see adult content?
Видео Блог о Строительстве Путь Домой с Александром Тереховым
Are you over 18 and want to see adult content?
Google Marketing Service Mission Viejo, Orange County, Irvine, Laguna Hills
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://chromecast.com
Are you over 18 and want to see adult content?
A complete backup of https://mallorvillas.com
Are you over 18 and want to see adult content?
A complete backup of https://badkissingen.de
Are you over 18 and want to see adult content?
A complete backup of https://boverket.se
Are you over 18 and want to see adult content?
A complete backup of https://falls.info
Are you over 18 and want to see adult content?
A complete backup of https://science.blog
Are you over 18 and want to see adult content?
A complete backup of https://larocheposay.de
Are you over 18 and want to see adult content?
A complete backup of https://streammonkey.com
Are you over 18 and want to see adult content?
A complete backup of https://konyajo.com
Are you over 18 and want to see adult content?
A complete backup of https://akpsi.org
Are you over 18 and want to see adult content?
A complete backup of https://premiertablelinens.com
Are you over 18 and want to see adult content?
A complete backup of https://aomedia.org
Are you over 18 and want to see adult content?
Text
SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. PARTNER PORTAL USER INSTRUCTIONS ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination)CMD 2021 | ORION
CMD 2021. Orion’s virtual Capital Markets Day 2021 for investors, analysts and media will be held on 26 May 2021 at 1.00 p.m – 4.00 p.m. EEST. At the event, Orion's management will provide an update on the company's strategy, business and research & development projects. The presentations will include updates from CEO Timo Lappalainen andORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
SYDÄMEN VAJAATOIMINNAN OIREET Sydämen vajaatoiminnan oireet. Oireet riippuvat sydämen vajaatoiminnan aiheuttajasta ja sen vaikeusasteesta, potilaan muista sairauksista, iästä sekä lääkityksestä. Väsymys, hengenahdistus ja turvotus kuuluvat sydämen vajaatoiminnan tyypillisimpiin oireisiin. Monet oireista ovat epäspesifisiä, eli ne voivat liittyämuuhunkin
LAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. MITTAUS JA TAVOITEARVOT Tästäkin syystä mittauksen tekee yleensä terveydenhoitaja. Yleisesti ottaen kotimittausten keskiarvo 135/85 mmHg vastaa terveydenhuollossa mitattua keskiarvoa 140/90 mmHg. Kun tiedät verenpaine- ja kolesteroliarvosi, voit laskea riskisi sairastua sydäninfarktiin tai vakavaan aivoverenkiertohäiriöön Terveyden ja hyvinvoinnin laitoksenSITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. PARTNER PORTAL USER INSTRUCTIONS ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination)CMD 2021 | ORION
CMD 2021. Orion’s virtual Capital Markets Day 2021 for investors, analysts and media will be held on 26 May 2021 at 1.00 p.m – 4.00 p.m. EEST. At the event, Orion's management will provide an update on the company's strategy, business and research & development projects. The presentations will include updates from CEO Timo Lappalainen andORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
SYDÄMEN VAJAATOIMINNAN OIREET Sydämen vajaatoiminnan oireet. Oireet riippuvat sydämen vajaatoiminnan aiheuttajasta ja sen vaikeusasteesta, potilaan muista sairauksista, iästä sekä lääkityksestä. Väsymys, hengenahdistus ja turvotus kuuluvat sydämen vajaatoiminnan tyypillisimpiin oireisiin. Monet oireista ovat epäspesifisiä, eli ne voivat liittyämuuhunkin
LAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. MITTAUS JA TAVOITEARVOT Tästäkin syystä mittauksen tekee yleensä terveydenhoitaja. Yleisesti ottaen kotimittausten keskiarvo 135/85 mmHg vastaa terveydenhuollossa mitattua keskiarvoa 140/90 mmHg. Kun tiedät verenpaine- ja kolesteroliarvosi, voit laskea riskisi sairastua sydäninfarktiin tai vakavaan aivoverenkiertohäiriöön Terveyden ja hyvinvoinnin laitoksenORION
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. PRESCRIPTION DRUGS AND SELF-CARE PRODUCTS Prescription drugs and self-care products. Orion has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our portfolio consists of a range of hundreds of products. Our product portfolio includes: Proprietary drugs developed by Orion itself. Substitutable genericdrugs.
AGM 2020 | ORION
AGM 2020. The 2020 Annual General Meeting of Orion was held on Wednesday, 6 May 2020. The decisions and related material are available here. Stock Exchange Release: Orion Corporation: Decisionsby the AGM 2020
PRESS RELEASES
2/8/2021 Orion and Bayer expand development program for darolutamide in prostate cancer. 1/20/2021 Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021. 1/18/2021 Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distributeDrontal® and
ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rulesBOARD COMMITTEES
The committee shall meet at least four times per year, and it shall report regularly to the Board. The committee concentrates particularly on matters pertaining to financial reporting and control in the Orion Group. Its duties include: monitoring and assessing the financing reporting system. monitoring and assessing the functioning and the INTRODUCING THE TURKU SITE: 4+ DECADES OF GMP COMPLIANT Introducing the Turku site: 4+ decades of GMP compliant pharma manufacturing. With 45 years of experience in GMP compliant pharma production, and its own R&D unit, Orion’s Turku site focuses especially on tablets, hormonal gels and semisolids, creams and ointments as well as anti-cancer drugs – and caters to all globalmarkets.
SYDÄMEN VAJAATOIMINNAN OIREET Sydämen vajaatoiminnan oireet. Oireet riippuvat sydämen vajaatoiminnan aiheuttajasta ja sen vaikeusasteesta, potilaan muista sairauksista, iästä sekä lääkityksestä. Väsymys, hengenahdistus ja turvotus kuuluvat sydämen vajaatoiminnan tyypillisimpiin oireisiin. Monet oireista ovat epäspesifisiä, eli ne voivat liittyämuuhunkin
LAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. KOLESTEROLIA ALENTAVA RUOKAVALIO Kolesterolia alentava ruokavalio. Korkean kolesterolin hoidossa tärkeää on terveellinen ruokavalio, joka sisältää hyvää, pehmeää rasvaa ja kuitupitoisia hiilihydraatteja, mutta niukasti kovia rasvoja, nopeita hiilihydraatteja ja sokeria. Ohjenuoraksi terveelliseen ruokavalioon kannattaa ottaa perinteinen lautasmalli:puolet kasviksia
powered by: Cookie Information The website uses cookies Orion and its partners use cookies to provide you with a better user experience, to measure statistically how you interact with our online services and to serve personalised content and advertising based on your interests. Cookies are used only on the basis of your consent, except for those cookies which are strictly necessary for the proper functioning of the site. By choosing “Accept all” you give your consent to the use of cookies and similar technologies. If you would like to decline the use of other than strictly necessary cookies please choose “Decline all”. You can always withdraw your cookie consent or change your cookie preferences by choosing the cookie icon at the bottom left corner of our websites. Read more about cookieshere. About cookies
Decline all Change preferences Accept all powered by: Cookie InformationPrivacy Controls
Orion and its partners use cookies to provide you with a better user experience, to measure statistically how you interact with our online services and to serve personalised content and advertising based on your interests. Cookies are used only on the basis of your consent, except for those cookies which are strictly necessary for the proper functioning of the site. By choosing “Accept all” you give your consent to the use of cookies and similar technologies. If you would like to decline the use of other than strictly necessary cookies please choose “Decline all”. You can always withdraw your cookie consent or change your cookie preferences by choosing the cookie icon at the bottom left corner of our websites. Read more about cookieshere. About cookies
Select all Deselect allStrictly necessary
Strictly necessary cookies help us make a website easy to navigate by activating basic functions such as page navigation and access to secure website areas. These cookies are automatically installed and can not be rejected as without these cookies, the website would not be able to work properly. Data Processor: GlobeNewswire, West Purpose: Ensures the website and application security. Data Processor Privacy Policy: http://globenewswire.com/Home/About/Privacy -------------------------Expiry: a year
Name: visid_incap_xxx Provider: .globenewswire.com Data Processor: Incapsula, Imperva Purpose: Ensures the website and application security. Data Processor Privacy Policy: https://www.incapsula.com/privacy-policy -------------------------Expiry: Session
Name: incap_ses_xxx
Provider: .globenewswire.com Data Processor: ReachMee Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: https://reachmee.com/privacy-policy/ -------------------------Expiry: 2 years
Name: _sp_id.xxx
Provider: web106.reachmee.com Data Processor: ReachMeePurpose:
Data Processor Privacy Policy: https://reachmee.com/privacy-policy/ -------------------------Expiry: Session
Name: nlbi_1819681
Provider: .globenewswire.com Data Processor: ReachMeePurpose: -
Data Processor Privacy Policy: https://reachmee.com/privacy-policy/ -------------------------Expiry: 7979 years
Name: G_ENABLED_IDPS Provider: .web106.reachmee.com Data Processor: Investis Digital Purpose: Supports the website's technical functions. Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: 7 days
Name: AWSALBCORS
Provider: otp.tools.investis.com Data Processor: GlobeNewswire, West Purpose: Supports the visual content and the website elements on thewebsite.
Data Processor Privacy Policy: http://globenewswire.com/Home/About/Privacy -------------------------Expiry: a year
Name: GNWTracker
Provider: pr.globenewswire.com Data Processor: Microsoft, ASP.NET Purpose: Supports the integration of a third-party platform on thewebsite.
Data Processor Privacy Policy: https://privacy.microsoft.com/en-us/privacystatement -------------------------Expiry: Session
Name: ASP.NET_SessionId Provider: pr.globenewswire.com Data Processor: EpiserverPurpose:
Data Processor Privacy Policy: https://www.episerver.com/legal/privacy-statement -------------------------Expiry: Session
Name: Orion_Prod
Provider: www.orion.fi Data Processor: Investis Digital Purpose: Supports the website's technical functions. Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: Session
Name: AWSELBCORS
Provider: irs.tools.investis.com Data Processor: GlobeNewswire, WestPurpose:
Data Processor Privacy Policy: http://globenewswire.com/Home/About/Privacy -------------------------Expiry: Session
Name: nlbi_1917628
Provider: .globenewswire.com Data Processor: Investis Digital Purpose: Required for the website to perform properly. Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: 7 days
Name: AWSALB
Provider: orion.dfs.investis.com Data Processor: GlobeNewswire, WestPurpose:
Data Processor Privacy Policy: http://globenewswire.com/Home/About/Privacy -------------------------Expiry: Session
Name: TBMCookie_331718653375599340 Provider: pr.globenewswire.com Data Processor: Cookie Information Purpose: Supports the website's technical functions. Data Processor Privacy Policy: https://cookieinformation.com/cookie-and-privacy-policy -------------------------Expiry: a year
Name: CookieInformationConsent Provider: www.orion.fi Data Processor: Investis Digital Purpose: Collects information about the users and their activity on the website. The information is used to track and analyze user behavior and to meet individual user needs. Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: Session
Name: AWSELB
Provider: irs.tools.investis.com Data Processor: Microsoft, ASP.NET Purpose: Supports the integration of a third-party platform on thewebsite.
Data Processor Privacy Policy: https://privacy.microsoft.com/en-us/privacystatement -------------------------Expiry: Session
Name: __RequestVerificationToken Provider: www.orion.fi Data Processor: Investis DigitalPurpose:
Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: 7 days
Name: AWSALBTG
Provider: otp.tools.investis.com Data Processor: EpiserverPurpose:
Data Processor Privacy Policy: https://www.episerver.com/legal/privacy-statement -------------------------Expiry: a month
Name: SelectedLanguage Provider: www.orion.fi Data Processor: ReachMee Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: https://reachmee.com/privacy-policy/ -------------------------Expiry: 30 minutes
Name: _sp_ses.xxx
Provider: web106.reachmee.com Data Processor: GlobeNewswire, WestPurpose:
Data Processor Privacy Policy: http://globenewswire.com/Home/About/Privacy -------------------------Expiry: Session
Name: nlbi_1917631
Provider: .globenewswire.com Data Processor: ReachMeePurpose:
Data Processor Privacy Policy: https://reachmee.com/privacy-policy/ -------------------------Expiry: Session
Name: reftracker_1349_14 Provider: web106.reachmee.com Data Processor: ReachMeePurpose:
Data Processor Privacy Policy: https://reachmee.com/privacy-policy/ -------------------------Expiry: Session
Name: reftracker_1349_9 Provider: web106.reachmee.com Data Processor: Investis Digital Purpose: Collects information about the users and their activity on the website. The information is used to track and analyze user behavior and to meet individual user needs. Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: 7 days
Name: AWSALB
Provider: viz.tools.investis.com Data Processor: Investis Digital Purpose: Collects information about the users and their activity on the website. The information is used to track and analyze user behavior and to meet individual user needs. Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: 7 days
Name: AWSALB
Provider: qfx.tools.investis.com Data Processor: Investis DigitalPurpose:
Data Processor Privacy Policy: https://www.investisdigital.com/privacy-statement -------------------------Expiry: 7 days
Name: AWSALBTGCORS
Provider: otp.tools.investis.com Data Processor: GlobeNewswire, WestPurpose:
Data Processor Privacy Policy: http://globenewswire.com/Home/About/Privacy -------------------------Expiry: Session
Name: GNWUserSessionId Provider: pr.globenewswire.comFunctional
Functional cookies make it possible to save information that changes the way the website appears or acts in order to make it more tailored for you. For instance these cookies help the website to remember your preferred language or region. Data Processor: Google Purpose: Ensures the website and application security. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: 6 months
Name: _GRECAPTCHA
Provider: .google.comStatistical
Statistical cookies help us to understand how visitors interact with the website, to count the number of visitors and measure traffic by collecting and reporting information. These cookies are used to improve the quality of the site. Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: 2 years
Name: _ga
Provider: .orion.fi
Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en ------------------------- Expiry: a few secondsName: ___utmvc
Provider: pr.globenewswire.com Data Processor: Google AnalyticsPurpose:
Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: 2 years
Name: _ga_xxx
Provider: .orion.fi
Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: a minute
Name: _gat_UA-xxx-xxxProvider: .orion.fi
Data Processor: Google Analytics Purpose: Collects information about the users and their activity on the website for analytics and reporting purposes. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: a day
Name: _gid
Provider: .orion.fi
Marketing
Marketing cookies are used to personalise the content ouf our websites and to track visitors across websites. The intention is to display and deliver advertising and personalised content that are relevant and interesting to the individual user. These cookies also include cookies from social media providers, which enable functions (such as share buttons), and are used when we embed videos within our website. Data Processor: Youtube, Google Purpose: Collects information about the users and their activity on the website through embedded video players with the purpose of delivering targeted advertising. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: Session
Name: YSC
Provider: .youtube.com Data Processor: Youtube, Google Purpose: Collects information about the users and their activity on the website through embedded video players with the purpose of delivering targeted advertising. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: 17 years
Name: CONSENT
Provider: .youtube.com Data Processor: Google Purpose: Remember your recent searches, your previous interactions with an advertiser's ads, or search results, and your visits to an advertiser's site to show you customized ads on Google. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: 6 months
Name: NID
Provider: .google.com Data Processor: Youtube, Google Purpose: Collects information about the users and their activity on the website through embedded video players with the purpose of delivering targeted advertising. Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: 6 months
Name: VISITOR_INFO1_LIVE Provider: .youtube.com Data Processor: Doubleclick, Google Purpose: Used for online marketing by collecting information about the users and their activity on the website. The information is used to target advertising to the user across different channels anddevices.
Data Processor Privacy Policy: https://policies.google.com/technologies/partner-sites?hl=en -------------------------Expiry: a year
Name: IDE
Provider: .doubleclick.netUnclassified
We are in the process of classifying unclassified cookies together with the providers of the individual cookies.Data Processor:
Purpose:
Data Processor Privacy Policy: -------------------------Expiry: Session
Name: AWSELB
Provider: ir.tools.investis.com Hide details Save settings powered by: Cookie InformationCookie Policy
Your consent applies to the following domains: orion.fi Cookie declaration last updated on 03.06.2021 When you visit Orion's online services, and if you give us your consent, your device receives one or more cookies which are sent from our online service to your browser.WHAT ARE COOKIES?
A cookie is a small datafile that is saved on your computer, tablet or mobile phone. A cookie is not a program that can contain harmful programs or viruses. We also use similar technologies, such as web beacons and pixels. When we refer to cookies in this Cookie Policy we also refer to such similar technologies. Cookies are divided into persistent cookies and session cookies. Persistent cookies remain on your device for a pre-defined period of time, after which they are erased, either automatically or when you delete cookies from your browser. Session cookies remain on your device only for the duration of your visit to our online services and are deleted when you close the browser. In our online services, cookies can be set either by the online service you visit (first party cookie) or by a third party, such as analytics provider (third-party cookie). WHY AND HOW DO WE USE COOKIES? We use cookies to improve user experience and to track the usage of our online services as well as to build better services. With cookies we can, for example, remember the language settings you choose in our online services so that you don't have to choose them again every time you visit our online services. In other words, we can improve the content and functionality of our online services and fix any errors in these services. We also use cookies in our marketing to target specific audiences. This enables us to provide you with content and marketing that interests you the most. For example, if based on the information that we collect with cookies, we can infer that you are interested in a specific product of Orion, we can provide you with content related to that specific product. Additionally, we measure the appeal of our services and sites. Data collected with cookies include the Cookie ID, IP address, the type of browser and device, and the browsing country, among other things. With your separate consent, we can connect the information we collect via cookies to other information we have collected from you, such as your name or email address. With this information, we can personalise our email marketing and newsletters based on your interests and behavior on our websites. A single individual may be identifiable also through other means, such as an IP address that can be connected to a specific individual. With cookies, we can also monitor, how you react to email marketing and newsletters we have sent to you, for example by tracking if you have opened emails we have sent to you and proceeded to our online services. You can read more about personal data processing practices of Orion Corporation from here. HOW LONG ARE COOKIES SAVED? The storage time of cookies saved on your device can vary. Session cookies are deleted after you close your browser, whereas thee time when persistent cookies are scheduled to expire is calculated from the last date you visited the homepage. When cookies expire, they are automatically deleted. You can view storage time of each cookie from “Privacy controls”. HOW CAN I PREVENT THE USE OF COOKIES OR DELETE COOKIES? Most browsers allow cookies by default. You can, however, block cookies and delete them via the settings of your browser or device. When ever you visit our online services for the first time or from a new browser or device, we ask for your consent to place cookies on your browser or device. We use only strictly necessary cookies without your consent to make our online services function properly. Preventing or deleting cookies may make our online service less user-friendly, and our online service will no longer remember things like your language settings. Deleting cookies from browser history will clear cookies but will not stop the use of cookies in the future. Alternatively, you can select “ingocnito” or “private browsing” when browsing through websites. You can delete cookies that you have previously accepted. If you are using a PC with a recent version of a browser, you can delete your cookies by using these shortcut keys: CTRL + SHIFT + Delete. If the shortcut keys do not work and/or you are using an Apple computer, you must find out what browser you are using and then click on the relevant link:* Internet Explorer
* Microsoft Edge
* Mozilla Firefox
* Google Chrome
* Opera
* Safari
* Flash cookies
* Apple
* Android
* Windows 7
Remember: If you are using several different browsers, you must delete the cookies in all of them. THIRD-PARTY COOKIES AND DATA COLLECTED In addition to our own cookies in our online services, we use third-party cookies. Third-party cookies are owned by third parties, such as web analytics and marketing technology providers. We use Google Analytics cookies , among others, for targeted advertising and for collecting measurement and analytics data from our online services. We have applied IP anonymization in our configuration of Google Analytics. This means that Google Analytics anonymizes the last octet of the user IP address as soon as technically feasible at the earliest possible stage of the collection network. The full IP address is never written to disk. Third-party cookies are owned by third parties, such as web analytics, marketing technology and social media providers. We use Google Analytics cookies , among others, for targeted advertising and for collecting measurement and analytics data from our online services. We have applied IP anonymization in our configuration of Google Analytics. This means that Google Analytics anonymizes the last octet of the user IP address as soon as technically feasible at the earliest possible stage of the collection network. The full IP address is never written to disk. Third party services may be able to identify the user with cookie data collected by such third parties and combine it with other data they have collected. Third-party services are subject to their own cookie and privacy policies, and, consequently, Orion is not responsible for third-party collection and handling of data. These third parties may transfer data that is stored in cookies by their web analytics and marketing technology tools to countries outside the European Economic Area (EEA). This means that your personal data may be processed or stored in a country that has less stringent data protection standards than those of the European Union. The personal data transferred outside the EEA is protected by the adequacy decision made by the EU Commission or by appropriate contractual arrangements. For more information, please contact Orion. If you wish to block cookies set by Google Analytics, you can download a browser plug-in from here. You can also use other tools and plug-ins to block cookies and tracking. We allow social media plug-ins in our online service so that you can, for example, visit our social media pages, use the Share buttons or see embedded video content from our social media pages. These services are subject to the Terms of Service of the social media service provider. Here you can find the Terms of Service for services such as Google, Facebook, Twitter, and YouTube. QUESTIONS REGARDING THE COOKIE POLICY If you have any questions about our Cookie Policy, or any concern about privacy at Orion Corporation, please contact us by e-mail at privacy@orion.fi. The cookie declaration itself is updated every month via Cookie Information. If you have any questions regarding the Cookie Information, you can send an email to info@cookieinformation.com. Orion reserves the right to make changes to its Cookie Policy should the Cookie Policy need to be updated owing to changes in legislation or other reasons. When we change the Cookie Policy in a material way, we will ask for a new cookie consent. Privacy Controls Accept all* __
* en
* fi
* Menu __
__ Menu __
suomeksi
ORION NOW
OTHER WEBSITES
* Wehale.life
ORION GROUP
* About Orion
* Products and services * Partnering and licensing* Investors
* Media
* Corporate Governance* Contact us
OTHER WEBSITES
* Fermion
*
CAREERS AT ORION
* Open vacancies
* Working at Orion
* Students
* Career stories
*
RESEARCH
* Orion R&D
* Research areas
* Research for patient well-being* R&D pipeline
* Scientific publications*
SUSTAINABILITY
* Policies
* Management of Sustainability * Sustainability Reports * Patient organisation collaboration * Stories about responsibility*
HEALTH PROFESSIONALS* Simdax.com
* Dexdor.eu
* Wehale.life
Orion Now Orion Now __News archive
2017
2016
2015
2014
Orion Group Orion Group __Orion's century
1910s
A superstar of Finnish chemistry It all began with Albin and woodfern Orion’s milestones in the 1910s1920s
A tireless promoter of children’s healthOne big family
Orion’s milestones in the 1920s1930s
Finnishness as an advertising asset PR in the 1930s: Welcome to the Vallila plant! Orion’s milestones in the 1930s1940s
A miracle drug amidst the warOrion relocated
Orion’s milestones in the 1940s1950s
A legendary school for laboratory assistants Finns’ favourite ointments Orion’s milestones in the 1950s1960s
The man behind the researchAn idyllic estate
Orion’s milestones in the 1960s1970s
How can I help you?
International horizons: rapid tests and Finnishness Orion’s milestones in the 1970s1980s
New address: Orionintie 1 “For manly pain” – from drugs to brands Orion’s milestones in the 1980s1990s
Joining forces with a competitor An inhaler that helps asthmatics and the atmosphere Orion’s milestones in the 1990s2000s
The long road to market The last hope for a heart patient Orion’s milestones in the 2000s2010s
Pink light to promote girls’ rights From a mobile phone factory to a pharmaceutical plant Orion’s milestone in the 2010sAbout Orion
Management
Board of Directors
Executive management boardOrion values
Mission and strategy Partnering and licensing Partnering opportunities Alliance and Partner Management Excellence Products and Services Prescription drugs and self-care productsVeterinary medicine
Active Pharmaceutical Ingredients Contract manufacturingInvestors
Orion as an investmentMarket reviews
Market reviews 2020
Market reviews 2019
Market reviews 2018
Market reviews 2017
Market reviews 2016
Market reviews 2015
Market reviews 2014
Market reviews 2013
Market reviews 2012
Market reviews 2011
Market reviews 2010
Market reviews 2009
Market reviews 2008
Market reviews 2007
CEO's review
CEO's Timo Lappalainen's reviews 2020 CEO Timo Lappalainen's reviews 2019 CEO Timo Lappalainen's reviews 2018 CEO Timo Lappalainen's reviews 2017 CEO Timo Lappalainen's reviews 2016 CEO Timo Lappalainen's reviews 2015 CEO Timo Lappalainen's reviews 2014 CEO Timo Lappalainen’s reviews 2013 CEO Timo Lappalainen’s reviews 2012 CEO Timo Lappalainen's reviews 2011 CEO Timo Lappalainen's reviews 2010 CEO Timo Lappalainen’s reviews 2009 CEO Timo Lappalainen’s reviews 2008CEO's reviews 2007
Financial InformationKey figures
Quarterly figures
Credit programmes
Outlook for 2021
Outlook for 2020
Outlook for 2019
Outlook for 2018
Outlook for 2017
Outlook for 2016
Outlook for 2015
Outlook for 2014
Outlook for 2013
Outlook for 2012
Outlook for 2011
Outlook for 2010
Outlook for 2009
Outlook for 2008
Outlook for 2007
Outlook for 2006
Basis for outlook
Accounting policies
Calculation of key figures Financial reviews and presentationsOther events
Capital Markets Days Financial StatementsShare information
Share capital and shares Share-related key figuresTreasury shares
Share price
Alternative exchanges monitor Historical share prices Total return calculatorDividends
Analysts
Consensus estimates
Shareholders
Major shareholders by shares Major shareholders by votesOwnership structure
Flagging notificationsInsider register
Conversion of shares Changes in shareholder's contacts Transactions of managers Messages to shareholders Annual General MeetingsAGM 2021
AGM 2020
AGM 2019
AGM 2018
AGM 2017
AGM 2016
AGM 2015
AGM 2014
AGM 2013
AGM 2012
AGM 2011
AGM 2010
AGM 2009
AGM 2008
AGM 2007
IR Calendar
Silent period
Archive
Investor Relations
CMD 2021
FAQ
Media
Stock Exchange ReleasesPress Releases
Managers' transactions Subscribe to releasesMaterial Bank
Disclosure Policy
Corporate Governance Corporate Governance Corporate Governance StatementAGM
Board of Directors
Activities and duties Principles Concerning Diversity of the Board of DirectorsBoard members
Mikael Silvennoinen
Timo Maasilta
Kari Jussi Aho
Pia Kalsta
Ari Lehtoranta
Veli-Matti Mattila
Hilpi Rautelin
Eija Ronkainen
Board Committees
Nomination Committee Authorisations of the Board of Directors CEO and Executive Management Board Activities and duties Introductions of the Executive Management Board membersTimo Lappalainen
Satu Ahomäki
Olli Huotari
Liisa Hurme
Jari Karlson
Virve Laitinen
Outi Vaarala
Employee representative Jani KorhonenRemuneration
Remuneration Report
Remuneration Policy
Share-based incentive plans Risks and internal controlStrategic risks
Operational risks
Financial risks
Compliance risks
Insider administrationAudit
Articles of Association Slavery and Human Trafficking StatementContact us
Drug safety and product information Locations and contact personsSites and offices
Pharmaceutical manufacturing Sales offices and representative officesAnimal Health
Fermion
Contact persons
Invoicing addresses
Research Research __Orion R&D
Orion's R&D PipelineResearch areas
Research for patient well-being Living with a diagnosisAsthma
ALS
Prostate cancer
Breast cancer
Parkinson's disease
Alzheimer's disease
Drug development
Scientific publications Clinical Research Privacy Statement Human Data Research Privacy Statement Orion Research Foundation Information about the Research Foundation The Administration of the Research Foundation Instructions for grant applicant Instructions for grant recipient Orion Research Foundation's grants Frequently asked questionsContacts
Sustainability Sustainability __Policies
Our approach to corporate responsibilityCode of Conduct
Human Resources PolicyEHS Policy
Quality Policy
Anti-Corruption Policy Supplier requirements Pharmaceutical R&D Ethics Policy Bioethics and Animal Welfare Using Human Tissues, GMO and Stem Cells Ethics in the Clinical Research Phases Ethics in the Marketing Phase Management of sustainability Sustainability Agenda Patient safety and reliable supply of medicationsEnvironment
Responsibility for Orionees Business ethics and transparency Sustainability Reports Sustainability Report 2020Previous reports
Patient organisation collaboration Healthcare professional collaboration Stories about responsibility Careers at Orion Careers at Orion __Open Vacancies
Applying for a job – questions and answers Working in the pharmaceutical industry Developing competence at Orion Building personnel well-beingCareer stories
Students
Health Professionals __ GLOBAL PARTNERSHIPS HELP ORION TO GROW AND DEVELOP Orion’s cooperation with other top experts in the pharmaceutical sector helps the company to expand its product selection and reach theglobal market.
Read more
Orion Now __
PRESCRIPTION DRUG SERIALISATION IMPROVES PATIENT SAFETY ORION’S SUSTAINABILITY REPORT 2020: THE PANDEMIC HIGHLIGHTED THE IMPORTANCE OF PATIENT SAFETY AND THE AVAILABILITY OF MEDICINES STRONGER ACTION FOR THE ENVIRONMENT Orion’s systematic work to reduce its carbon footprint has proven effective. The company is therefore making a commitment to an even stricter goal: achieving carbon neutrality in its own operations by2030.
Read more
CARBON FOOTPRINT ASSESSMENT OF ORION’S DRY POWDER INHALERS ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED FOR BETWEEN 1 AUGUST AND 10 SEPTEMBER 2021Read more
RESEARCH AREAS
Orion develops new pharmaceuticals in three therapy areas. Orion’s pharmaceutical R&D focuses on the central nervous system, cancer and critical care, and inhalable Easyhaler® pulmonary drugs. Orion also develops veterinary and generic drugs.Read more
Research __
ORION'S R&D PIPELINE SCIENTIFIC PUBLICATIONS A list of recent posters presented at congresses and articles published in peer reviewed scientific journals.Read more
FINANCIAL REVIEWS AND PRESENTATIONS Orion published Interim Report for January–March 2021 on Tuesday, 27 April 2021. The release and related presentation material as well as link to the live webcast and teleconference details are availablehere.
Read more
Orion Group __
AGM 2021
The Annual General Meeting of Orion Corporation was held on Thursday 25 March 2021 at Orion's Head Office in Espoo. The decisions and related material are available here.Read more
FINANCIAL STATEMENTS Orion Group's Financial Statement documents for 2020 are availablehere.
Read more
PRESS RELEASES
5/26/2021
Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available5/25/2021
Orion to investigate possible sale of its pharmaceutical manufacturing plant in Kuopio, Finland5/17/2021
Orion Animal Health’s Bonqat® (pregabalin) receives positiveCVMP opinion
5/4/2021
Invitation to Orion’s Virtual Capital Markets Day on 26 May 2021 STOCK EXCHANGE RELEASES5/28/2021
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)5/27/2021
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)5/20/2021
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)5/19/2021
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) WORKING IN THE PHARMACEUTICAL INDUSTRY Orion is the largest employer in the Finnish pharmaceutical industry. It is considered to be a good and reliable employer, which is also indicated by its lower-than-average employee turnover.Read more
Careers at Orion __ ORION IS ONE OF THE MOST POPULAR EMPLOYERS IN FINLAND Orion was ranked 3rd in the natural sciences category in both Universum Finland's 2021 Students and 2020 Professionals surveys.Read more
OPEN VACANCIES
See all open vacancies here.Read more
CONTRACT MANUFACTURINGCRITICAL CARE
One key area of Orion's business is Critical Care. Our portfolio includes Simdax® for acute heart failure and Precedex® and Dexdor® for sedation. Read more about Orion's proprietary products and other human pharmaceuticals.Read more
FOR HEALTHCARE PROFESSIONALS Are you a physician, vet, pharmacist or another healthcare professional? 'Health Professionals' site offers an easy access to our websites for professionals.Read more
Health Professionals __* __
* __
Change country
suomeksi
ORION NOW
FOLLOW US
* Twitter (IR)
* Youtube
ORION GROUP
* About Orion
* Products and services * Partnering and licensing* Investors
* Media
* Sustainability
* Corporate Governance * Health professionalsRESEARCH
* Orion R&D
* Research areas
* Research for patient well-being* R&D pipeline
* Scientific publicationsCAREERS AT ORION
* Open vacancies
* Working at Orion
* Students
* Career stories
OTHER WEBSITES
* fermion
* Orion in other countries* Contact us
* Privacy
* Cookie Policy
* About this website Orion Corporation, Orionintie 1A, 02200 Espoo, PO Box 65, FI-02101 Espoo, Finland. Phone +358 10 4261 © Copyright Orion Corporation. Company code, VAT 19992126.Sulje
PAHOITTELUT HÄIRIÖSTÄ! Kiitos mielenkiinnostasi Orionia kohtaan. Joulun alla Orion ja Omaishoitajat ja läheiset -liitto haluavat kiinnittää huomiosi omaishoitajien tärkeään työhön - ja antaa hyvän kiertää. Suomessa on yli 300 000 omaishoitotilannetta. Lahjoita Välittämö100-palveluun vaikkapa lehtitilaus tai elämyslahjakortti ja anna tämän joulun paras aineeton lahja.Tule mukaan
#välittämö100
Tämä on kampanjasivu. Orion.fi-osoitteeseen pääsee sulkemalla tämän viestin oikeasta yläkulmasta.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0